baber/WOPTO huggingface dataset:
Patent CS-274717-B2 (CS)
Title: Precipitation method of somatotropin chemically associated with multivalent metal
Inventor: MITCHELL JAMES WILLIAM
IPC: A61K47/44
Filed: 1985-10-03
Abstract: Non-aq. compsn. comprises at least 10wt.% of a biologically active polypeptide (I) and, as a continuous phase of the compsn., a biocompatible oil (II). Also claimed is a non-aq. compsn. of 15-40wt.% of a bovine somatotropin (Ia) chemically associated with zinc, 2-5wt.% of an aluminium mono- or di-stearate (IIIa) and, as a continuous phase of the compsn., a biocompatible vegetable oil. (Ia) has a particulate median vol. dia. of no greater than 5 microns and is present in a wt. ratio to the stearate of at least about 3. (Ia) chemically associated with non-toxic polyvalent metal is also new, pref. 0.3-2wt.% zinc.
Patent JP-3790289-B2 (JP)
IPC: C07C311/10
Filed: 1996-01-11
Granted: 2006-06-28
Abstract: Hetero-cycloalkyl derivs. of formula (I) and their enantiomers and diastereoisomers are new. R1 = alkyl opt. substd. by Q; or cycloalkyl or cycloalkylalkyl, both opt. substd. by Q'; A together with the benzene gp. = tetrahydronaphthalene, dihydronaphthalene, naphthalene, benzothiophene, 2,3-dihydrobenzothiophene; or indoline or indole both opt. N-substd. by Ra, CORa or CO2Ra; Ra = alkyl, Ph or phenylalkyl; R2 = H or alkyl; R3 = C(=X)R4 or C(=X')NHR5; X, X' = S or O; R4 = H, alkenyl, alkynyl, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; R5 = H, alkyl opt. substd. by Q, or cycloalkyl or cycloalkylalkyl both opt. substd. by Q'; alkyl, alkoxy = 1-6C; alkenyl, alkynyl = 2-6C; cycloalkyl = 3-8C; Q = halo, OH, alkyl or alkoxy; Q' = halo, alkyl or oxo.
Patent AU-649114-B2 (AU)
Title: Bismuth-containing superconducting material and process for producing it
Inventor: HETTICH BERNHARD
IPC: H01L39/24
Filed: 1992-03-18
Granted: 1994-05-12
Abstract: The invention relates to an oxide-ceramic superconducting material which contains bismuth, strontium, calcium and copper, having an overall composition of BiyCa2Sr2Cu3Ox, where y is an integer from 2.35 to 2.6 and x is about 10 to 12. The material has a critical temperature T above 105 K and has a proportion of the phase Bi2Sr2Ca2Cu3Ox of at least 85% by volume. The invention also relates to a process for producing a bismuth-containing superconducting material which comprises holding the oxides or oxide precursors of bismuth, strontium, calcium and copper at a temperature in the range from 850 DEG  to 890 DEG  C. over a time span of a plurality of hours and adhering to the following atomic ratios: Bi:Cu>2:3 Ca:Sr=0.9 to 1.50  SIGMA (Sr+Ca):Cu=4.2:3 to 4:3.33 Bi: SIGMA (Sr+Ca)=2.35:4 to 3.1:4
Patent AU-777948-B2 (AU)
Title: Concentrated aqueous bromine solutions and their preparation
Inventor: MOORE ROBERT M JR
IPC: A01N59/00
Filed: 2000-11-06
Granted: 2004-11-04
Abstract: A concentrated liquid biocide composition is produced by a continuous process. The process comprises continuously feeding into mixing apparatus (i) bromine chloride and (ii) an aqueous solution of alkali metal salt of sulfamic acid. These are proportioned to produce an aqueous product having an active bromine content of at least 100,000 ppm (wt/wt), and an atom ratio of nitrogen to active bromine from (i) and (ii) greater than 0.93:1. The desired product which is thus continuously formed, is withdrawn from the mixing apparatus at a rate sufficient to enable the continuous feeding to be maintained. Thus, the withdrawal of the product can be continuous or intermittent, depending upon the type of mixing apparatus being used. In various embodiments of the invention, the bromine chloride is continuously produced from separate feed streams of bromine and chlorine by maintaining such streams under automatic feed rate control whereby the streams are continuously proportioned to come together to form bromine chloride.
Patent AU-712409-B2 (AU)
Title: Hybrid protein between CS from plasmodium and HBsAG
Inventor: WILDE MICHEL DE
IPC: C12N7/04
Filed: 1997-02-14
Granted: 1999-11-04
Abstract: A novel hybrid protein is provided which comprises a portion of the CS protein of P. falciparum and the surface antigen of Hepatitis B virus. The use of this protein for vaccination purposes is disclosed.
Patent AU-768827-B2 (AU)
Title: Intrabodies with defined framework that is stable in a reducing environment and applications thereof
Inventor: MAUR ADRIAN AUF DER
IPC: C12N7/01
Filed: 2000-12-18
Granted: 2004-01-08
Abstract: Methods for the generation of a CDR library with a defined framework that is stable and soluble in a reducing environment are described as well as thus obtained library of intrabodies.
Patent AU-766214-B2 (AU)
Title: Drill/driver chuck
Inventor: WALKER ANDREW
IPC: B23B45/00
Filed: 2000-03-29
Granted: 2003-10-09
Abstract: A drill/driver chuck mechanism has a cylindrical member (2) with a central axial bore (4). A plurality of further bores (6) are slanted with respect to the central axial bore (4). Jaws (8) each associated with a bore (6) are moveable via a jaw actuator (10). A jaw locking means (32-60) is coupled to the jaw actuator (10). The jaw locking means may move between an open position and a closed position such that the jaws may be locked within their respective bore (6) regardless of the degree of protrusion of the jaws (8) into the central axial bore (4). <IMAGE>
Patent AU-566667-B2 (AU)
Title: Grease composition
Inventor: HORODYSKY ANDREW GENE
IPC: C10M169/06
Filed: 1984-02-01
Granted: 1987-10-29
Abstract: Grease compositions, wherein the grease is thickened with a metal hydroxyl-containing soap grease thickener are provided. Other essential ingredients of the compositions include borated hydrocarbyl epoxides and phosphorus and sulfur moieties.
Patent AU-560604-B2 (AU)
Title: Dense star polymers and a process for producing dense star polymers
Inventor: TOMALIA D A DEWALD J R
IPC: C09D201/00
Filed: 1983-12-29
Granted: 1987-04-09
Abstract: This invention is directed to dense star polymers and to a process for producing dense star polymers. The star polymers of this invention have at least one core branch eminating from a core, each core branch having at least one terminal group provided that (1) the ratio of terminal groups to the core branches is greater than 1 : 1, (2) the density of terminal groups per unit volume in the polymer is at least 1.5 times that of conventional star polymer having similar core and monomeric moieties and a comparable molecular weight and number of core branches, each of such branches of the conventional star polymer bearing only one terminal group and (3) a molecular volume that is no more than 60 percent of the molecular volume of said conventional star polymer. Such star polymers are useful as demulsifiers for oil/water emulsions, wet strength agents in the manufacture of paper and agents for modifying viscosity in aqueous formulations such as paints.
Patent AU-690280-B2 (AU)
Title: Synthetic peptide analogs of lung surfactant protein SP-C
Inventor: NAVE RUDIGER
IPC: C12P21/02
Filed: 1995-05-27
Granted: 1998-04-23
Abstract: PCT No. PCT/EP95/02028 Sec. 371 Date Nov. 27, 1996 Sec. 102(e) Date Nov. 27, 1996 PCT Filed May 27, 1995 PCT Pub. No. WO95/32992 PCT Pub. Date Dec. 7, 1995Polypeptide analogs of human the human lung surfactant protein, SP-C, are provided. The polypeptides have the following structure:   <IMAGE>    <IMAGE>    <IMAGE>    <IMAGE>   wherein A is H or Phe, B is Phe or Trp, and C is Ile, Leu, or Ser. They exhibit surfactant activity and are useful in the treatment of respiratory distress syndromes in premature infants and adults.
Patent AU-759419-B2 (AU)
Title: Surgical guide body
Inventor: FREI RETO
IPC: A61B17/80
Filed: 2000-03-07
Granted: 2003-04-17
Abstract: A guide body is designed to receive longitudinal fixation elements such as wires nails, pegs or screws which are to be anchored within bone. The guide body includes a top surface, a bottom surface, and a number of openings connecting the top surface with the bottom surface. The central axes of at least two of the openings are transverse to each other. The guide body permits the insertion of fixation elements at various angles with respect to each other. The guide body may prevent fixation elements which extend into the intramedullary region or the spongiosa from being displaced either in the proximal or in the distal direction.
Patent AU-616236-B2 (AU)
Title: Pharmaceutical preparation for treating immunodeficiency conditions
Inventor: YAKOVLEV GERMAN MIKHAILOVICH
IPC: A61K9/08
Filed: 1988-12-14
Granted: 1991-10-24
Abstract: A pharmaceutical preparation for treating immunodeficiency conditions consists of an active substance-peptide having the structure H-L-Glu-L- tau rp-OH, and of a pharmaceutical diluent.
Patent AU-626227-B2 (AU)
Title: Attenuated viruses
Inventor: ALMOND JEFFREY WILLIAM
IPC: A61K39/125
Filed: 1989-01-05
Granted: 1992-07-23
Abstract: An attenuated enterovirus or rhinovirus, suitable for use as a vaccine, has an attenuating mutation at least at a position which is, or corresponds with, position 479 and/or 482 of poliovirus type 3 Leon strain.
Patent AU-756432-B2 (AU)
Title: A method and a regulation device for an injection pump
Inventor: ERIKSSON INGEMAR
IPC: F02D1/06
Filed: 1999-11-23
Granted: 2003-01-16
Abstract: The invention is related to a method and a regulation device to be able to regulate the adjustment of the maximum supplyable fuel amount in an injection pump for a diesel engine, in that the maximum supplyable fuel amount is regulated in dependence on a control pressure from the intake pressure of the engine. The regulation device comprises an adjusting device (13) having a first member (16) which by actuation from a control pressure from the intake system of the engine in dependence on this control pressure can influence an adjustment arm (11) for full load amount in the injection pump (1). The adjusting device is applicable, without reconstruction of the injection pump, in an already existing opening in the pump housing.
Patent AU-608126-B2 (AU)
Title: Laying tiles using a tile adhesive
Inventor: AYDIN ORAL
IPC: C09J11/08
Filed: 1989-03-03
Granted: 1991-03-21
Abstract: Laying of tiles by means of a tile adhesive based on a polymer emulsion and customary additives, containing a compound of the general formula I as thickener 
<IMAGE>
 where
 R = a radical of a 2- to 6-hydric alcohol of from 2 to 10 carbon atoms, attached by oxygen,
 R<1> = an alkyl, alkoxymethyl or alkenyloxymethyl radical or a mixture of these radicals, each having from 16 to 30 carbon atoms in the alkyl, alkoxy or alkenyloxy radical,
 A = -CH2CH2-O- (=EO) alone or mixed with 
<IMAGE>
 where at least 50 mol %, preferably at least 70 mol % of A is -CH2CH2O-,
 x = 12 to 500,
 y = an average (averaged over numerous molecules) from 0.3 to 5, preferably from 0.5 to 2, n = an integer from 2 to 6.
Patent AU-720335-B2 (AU)
Title: Bearing arrangement
Inventor: LEIJONBERG GUNNAR
IPC: F16H25/08
Filed: 1997-07-10
Granted: 2000-05-25
Abstract: The present invention is for a bearing arrangement by a device for transmission of power where linear motion is transmitted into rotating motion or the like. The bearing means at the cam disc machine according to the invention is so made that the rotating cam disc is enclosed by a stationary housing whereby bearing between the stationary and rotating parts is arranged only on one side of the cylinder bore and in connection to the outgoing shaft.
Patent AU-657214-B2 (AU)
Title: New derivatives of 7-ethynyl alpha-(methoxymethylene) 1-naphthalene acetic acid, their preparation process and their use as pesticides
Inventor: BENOIT MARC
IPC: C07C69/734
Filed: 1993-04-13
Granted: 1995-03-02
Abstract: The application relates to the products (I): <IMAGE>  in which:   - R represents H, halogen or alkyl which is linear, branched or cyclic, optionally interrupted by one or a number of O, S or N, or R represents optionally substituted aryl, aryloxy or heterocyclic aryl or <IMAGE> with p = 0 to 6, or R represents <IMAGE> with Ra, Rb and Rc = alkyl or R represents <IMAGE> with a and b = H, halogen, OH, alkyl or alkoxy or a and b together form a cycloalkyl and R' has one of the values of R,   - R2 and R3 represent H, alkyl or <IMAGE> to their process of preparation and to their application as pesticidal agent.
Patent AU-666930-B2 (AU)
Title: Portable hand-held power assister device
Inventor: ARMBRUSTER RANDY E
IPC: A61M5/20
Filed: 1993-04-20
Granted: 1996-02-29
Abstract: A hand-held power assister device is provided for injecting liquid, such as contrast media, into the vascular system of a mammal at a controlled rate from a syringe. The device comprises a pistol-shaped casing (10), a syringe (12) having a slideable piston (48) therein removably coupled to the casing (10) and drive means, (22,30,24,26) contained in the casing, for driving the piston in the syringe to deliver the liquid to the patient. The drive means preferably comprises a battery-powered motor (22) to generate angular rotation and a lead screw (30) rotatably coupled with the motor by gear means (24,26) to convert the angular rotation to linear motion, the screw (30) having at one end a female coupling means (38) for engaging with a male coupling means (46) on the piston (48). The use of the piston for the angiographic or urographic examination of a mammal is described. <IMAGE>
Patent AU-689331-B2 (AU)
Title: CDR-grafted type III anti-CEA humanized mouse monoclonal antibodies
Inventor: HANSEN HANS J
IPC: A61K47/48
Filed: 1995-09-28
Granted: 1998-03-26
Abstract: A humanized monoclonal antibody, comprising the complementarity-determining regions of a parental murine Class III, anti-CEA monoclonal antibody engrafted to the framework regions of a heterologous antibody, wherein the humanized monoclonal antibody retains the binding specificity of, but is less immunogenic in a heterologous host than, the parental murine monoclonal antibody. A preferred murine Class III, anti-CEA monoclonal antibody is the MN-14 antibody and the preferred heterologous antibody is from a human. Also provided are DNA constructs and vectors for producing the humanized monoclonal antibodies, and diagnostic and therapeutic conjugates using same.
Patent AU-617489-B2 (AU)
Title: Pyridazinone derivatives
Inventor: REDPATH JAMES
IPC: C07D493/04
Filed: 1989-07-07
Granted: 1991-11-28
Abstract: The invention relates to pyridazinone compounds of the general formula I: <CHEM>  wherein R<1> represents one to four substituents, which may be the same or different and are selected from H, OH, halogen, NO2, unsubstituted or C1-C4 alkyl substituted amino, C1-C4 alkyl, C1-C4 halogen substituted alkyl, O-ALK-NR<4>R<5>, C1-C4 alkoxy, whereby two substituents taken together may also represent a methylenedioxy group ;  R<2> and R<3> represent independently H or C1-C4 alkyl; R<4> and R<5> represent independently H or C1-C4 alkyl, or form together with the nitrogen a 5- or 6- membered ring;  X represents S or O;  the dotted line represents an optional bond;  and their pharmaceutically acceptable salts. The compounds according to the invention have a cardiotonic, blood platelet aggregation inhibiting, systemic vasodilator, pulmonary vasodilator, and bronchodilator activity, and more particularly they show a very potent increase of the force of the muscular contractions of the heart, reduce afterload on the heart, improve pulmonary blood flow, and improve airways ventilation.
Patent AU-657624-B2 (AU)
Title: Hydroxy protecting group removal in penems
Inventor: BEDESCHI ANGELO
IPC: C07D499/897
Filed: 1993-04-15
Granted: 1995-03-16
Abstract: The present invention relates the removal of t-butyldimethylsilyl protecting groups in the preparation of penems which are useful antibiotics. The invention provides a process for preparing a compound of the formula I:    <IMAGE>  I  wherein R is a free or protected hydroxy or amino group or an alkoxy, acyloxy or an optionally substituted carbamoyloxy group, and R1 is selected from: a) hydrogen; b) a C2-C4 alkenyl group; c) a p-NO2 benzyl group; d) a linear or branched alkanoyloxy C1-C2 alkyl group; and e) (2-oxo-1,3-dioxolen-4-yl)methyl optionally substituted by C1-C4 alkyl at the 5-position or a pharmaceutically acceptable salt thereof, which process comprises reacting a compound of the formula II:    <IMAGE>  II
Patent AU-713677-B2 (AU)
Title: Electrosurgical instrument
Inventor: GOBLE NIGEL MARK
IPC: A61B18/12
Filed: 1995-12-18
Granted: 1999-12-09
Abstract: An electrosurgical cutting device comprises an instrument body (10), and first and second cutting blades (12,14) at least one of which is pivotally mounted on the body to execute a scissor action with respect to the other blade. Electrical supply conductors (24) associated with the body (10) supply an electrosurgical voltage to the first and second blades (12,14). The first blade (12) is a composite blade comprising a conductive outer electrode (12A), an inner conductive layer (12C) and, sandwiched between the outer electrode and the inner layer, an insulating layer (12B). The supply conductors (24) are connected respectively to the outer electrode (12A) and to the inner layer (12C). <IMAGE>
Patent AU-574198-B2 (AU)
Title: Penem derivatives
Inventor: ALPEGIANI MARCO
IPC: A61K31/43
Filed: 1985-06-27
Granted: 1988-06-30
Abstract: Compounds of the formula (I) 
<CHEM>
 wherein
 R is a C1-C3 alkyl group substituted by a free or protected hydroxy;
 Q<(+)> represents a group 
<CHEM>
 wherein R1 is always a substituent,
 each of R2 and R3 is, independently, hydrogen or R1 provided that, when R2 and R3 are both hydrogen, then R1 is not a group 
<CHEM>
 wherein R4 and R5 are both hydrogen; and the pharmaceutically or veterinarily acceptable salts thereof. 
<??>Methods of producing them and their uses. The penem derivative possess valuable properties in pharmaceutical and veterinary compositions.
Patent AU-705332-B2 (AU)
Title: Method and bag set for concentrating white cells
Inventor: RUBINSTEIN PABLO
IPC: A01N1/02
Filed: 1995-12-05
Granted: 1999-05-20
Abstract: A therapeutic product formed from a high concentration of white blood cells having a high degree of cell viability. The white blood cells are sequestered from their normal population presence in whole blood by placing the blood into a container and preventing coagulation of the blood, separating the blood into two components, one of which is extremely rich in white blood cells through the use of a reagent and centrifugation, sequestering the white cell concentration, and freezing the white cells.
Patent AU-777940-B2 (AU)
Title: Methods and apparatus for treating disc herniation
Inventor: FERREE BRET A
IPC: A61B17/56
Filed: 2000-05-30
Granted: 2004-11-04
Abstract: Methods and apparatus for treating disc herniation provide a conformable device which assumes a first shape associated with insertion and a second shape or expanded shape to occlude the defect which typically follows partial discectomy. The device may take different forms including patches size to cover the defect or plugs adapted to fill the defect. In a preferred embodiment, however, the device is a gel or other liquid or semi-liquid which solidifies to occlude the defect from within the body of the disc itself. In another preferred embodiment, a mesh screen is collapsed into an elongated form for the purposes of insertion, thereby minimizing the size of the requisite incision while avoiding delicate surrounding nerves. Such a configuration also permits the use of instrumentation to install the device, including, for example, a hollow tube or sheath adapted to hold the collapsed screen, and a push rod to expel the collapsed device out of the sheath for use in occluding the disc defect. A device may further include one or more anchors to assist in permanently affixing the device with respect to the defect.
Patent AU-687017-B2 (AU)
Title: Heterocyclic ether compounds that enhance cognitive function
Inventor: ABREO MELWYN A
IPC: A61K31/427
Filed: 1993-10-08
Granted: 1998-02-19
Abstract: Novel heterocyclic ether compounds of formula (I), wherein A, B and R<2> are specifically defined, or pharmaceutically-acceptable salts or prodrugs thereof, which are selective and potent ligands at cholinergic channel receptors, useful in the treatment of cognitive, neurological and mental disorders characterized by decreased cholinergic function.
Patent AU-622794-B2 (AU)
Title: Optical information recording medium and recording method
Inventor: HAMADA EMIKO
IPC: G11B7/2542
Filed: 1990-04-26
Granted: 1992-04-16
Abstract: An optical information recording medium comprising a light transmitting substrate, a light absorptive layer containing at least one light absorbing substance formed on the substrate and a light reflective layer made of a metal film formed on the light absorptive layer, wherein an optical parameter represented by  rho  = nabsdabs/ lambda  wherein nabs is the real part of the complex refractive index of the light absorptive layer, dabs is the average thickness of the light absorptive layer and  lambda  is the wavelength of a reading laser beam, is 0.6< rho <1.6.
Patent AU-525060-B2 (AU)
Title: Infusion solution of amino acids + kinins
IPC: A23L1/30
Filed: 1980-01-21
Granted: 1982-10-14
Abstract: There are provided infusion solutions for a low-caloric parenteral nutrition which contain 10 to 200 grams (preferably 50 to 100 grams) of essential and non-essential amino acids as well as 50 to 10,000 mu g (200 to 1000  mu g) of kinin per one liter of infusion solution, and mineral salts.
Patent AU-670346-B2 (AU)
Title: Asynchronous switching network
Inventor: GASS RAYMOND
IPC: H04Q11/04
Filed: 1994-02-09
Granted: 1996-07-11
Abstract: Asynchronous switching network for a communications installation kernel (1) including packet-mode support units (2, 3, 6) directly or indirectly interconnected in point-to-point mode by links (L) which are physically structured and managed in terms of time in an identical way. It includes a traffic regulation system including access control means (14, 8, 16) specific to each packet-mode support unit, in order to allow every unit to fix the order of communication of the packets sent to it by the other packet-mode support units. Each transmission of a packet by one unit to another involves the sending of a request by the unit wishing to send to the unit with which it wants to communicate and the sending of an agreement in the opposite direction from the latter, for each of the packet elements separately transmitted between these units. <IMAGE>
Patent AU-638719-B2 (AU)
Title: Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
IPC: C12Q1/68
Filed: 1990-05-18
Granted: 1993-07-08
Abstract: A new virus, Hepatitis C virus (HCV), which has proven to be the major etiologic agent of blood-borne NANBH, was discovered by Applicant. Reagents for isolating, amplifying, and detecting HCV polynucleotides are provided. These reagents are oligomers comprised of polynucleotide sequences which are capable of forming hybrid structures with HCV target polynucleotide sequences.
Patent AU-674929-B2 (AU)
Title: Steel containing ultrafine oxide inclusions dispersed therein
Inventor: MAEDE HIROBUMI
IPC: C21C7/00
Filed: 1994-02-16
Granted: 1997-01-16
Abstract: This invention discloses a steel containing up to 1.2 wt % of C, 0.01 to 0.10 wt % of Al, up to 0.0050 wt % of O and Mg in an amount satisfying the relation (1): total oxygen wt % x 0.5 </= total Mg wt % < total oxygen wt % x 0.7, wherein the proportion of the number of oxide inclusions preferably satisfies the formula (2): (the number of MgO.Al2O3's + the number of MgO's)/total number of oxide inclusion particles >/= 0.8.